1887

Abstract

The immune system uses both virus-specific T cells and B cells to control the acute and latent phases of respiratory infection with the murine gammaherpesvirus 68 (γHV-68). We sought to further define the important effector mechanisms for CD8 T cells. First, depletion of the CD4 T cells resulted in a failure of most animals to drive the virus into latency, although lytic virus in the lung was reduced by approximately 1000-fold from its peak. Second, the absence of either perforin or Fas alone had no impact on the ability to reduce titres of lytic virus in the lung. Further neutralization of IFN-γ in CD4-depleted P, P or Fas mice had no effect. To define the requirements for Fas or perforin more clearly, two sets of chimeric mice were constructed differing in perforin expression by the T cells, and Fas on infected epithelial cells or lymphocytes. Animals with P T cells and a Fas lung failed to limit the shedding of infectious virus, regardless of whether CD4 T cells were present. In addition, we noted that having P T cells in irradiated Fas hosts caused a lethal disease that was not apparent in the non-chimeric (unirradiated) P (Fas) mice. In another set of chimeric mice, P T cells were able to limit persistent infection of B cells that expressed Fas, but not B cells that were Fas-deficient. These studies demonstrate that some degree of cytotoxicity via either perforin or Fas is essential for CD8 T cells to control this DNA virus.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-82-8-1971
2001-08-01
2024-04-20
Loading full text...

Full text loading...

/deliver/fulltext/jgv/82/8/0821971a.html?itemId=/content/journal/jgv/10.1099/0022-1317-82-8-1971&mimeType=html&fmt=ahah

References

  1. Allan W., Tabi Z., Cleary A., Doherty P. C. 1990; Cellular events in the lymph node and lung of mice with influenza. Consequences of depleting CD4+ T cells. Journal of Immunology 144:3980–3986
    [Google Scholar]
  2. Bird C. H., Sutton V. R., Sun J., Hirst C. E., Novak A., Kumar S., Trapani J. A., Bird P. I. 1998; Selective regulation of apoptosis: the cytotoxic lymphocyte serpin proteinase inhibitor 9 protects against granzyme B-mediated apoptosis without perturbing the Fas cell death pathway. Molecular and Cellular Biology 18:6387–6398
    [Google Scholar]
  3. Cardin R. D., Brooks J. W., Sarawar S. R., Doherty P. C. 1996; Progressive loss of CD8+ T cell-mediated control of a gamma-herpesvirus in the absence of CD4+ T cells. Journal of Experimental Medicine 184:863–871
    [Google Scholar]
  4. Cavanaugh V. J., Guidotti L. G., Chisari F. V. 1998; Inhibition of hepatitis B virus replication during adenovirus and cytomegalovirus infections in transgenic mice. Journal of Virology 72:2630–2637
    [Google Scholar]
  5. Christensen J. P., Doherty P. C. 1999; Quantitative analysis of the acute and long-term CD4+ T-cell response to a persistent gammaherpesvirus. Journal of Virology 73:4279–4283
    [Google Scholar]
  6. Christensen J. P., Cardin R. D., Branum K. C., Doherty P. C. 1999; CD4+ T cell-mediated control of a γ-herpesvirus in B cell-deficient mice is mediated by IFN-γ. Proceedings of the National Academy of Sciences, USA 96:5135–5140
    [Google Scholar]
  7. Doherty P. C., Topham D. J., Tripp R. A., Cardin R. D., Brooks J. W., Stevenson P. G. 1997; Effector CD4+ and CD8+ T-cell mechanisms in the control of respiratory virus infections. Immunological Reviews 159:105–117
    [Google Scholar]
  8. Esser M. T., Dinglasan R. D., Krishnamurthy B., Gullo C. A., Graham M. B., Braciale V. L. 1997; IL-2 induces Fas ligand/Fas (CD95L/CD95) cytotoxicity in CD8+ and CD4+ T lymphocyte clones. Journal of Immunology 158:5612–5618
    [Google Scholar]
  9. Fleck M., Kern E. R., Zhou T., Podlech J., Wintersberger W., Edwards C. K., Mountz J. D. 1998; Apoptosis mediated by Fas but not tumor necrosis factor receptor 1 prevents chronic disease in mice infected with murine cytomegalovirus. Journal of Clinical Investigation 102:1431–1443
    [Google Scholar]
  10. Franco M. A., Tin C., Rott L. S., VanCott J. L., McGhee J. R., Greenberg H. B. 1997; Evidence for CD8+ T-cell immunity to murine rotavirus in the absence of perforin, Fas, and gamma interferon. Journal of Virology 71:479–486
    [Google Scholar]
  11. Guidotti L. G., Ando K., Hobbs M. V., Ishikawa T., Runkel L., Schreiber R. D., Chisari F. V. 1994; Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice. Proceedings of the National Academy of Sciences, USA 91:3764–3768
    [Google Scholar]
  12. Guidotti L. G., Rochford R., Chung J., Shapiro M., Purcell R., Chisari F. V. 1999; Viral clearance without destruction of infected cells during acute HBV infection. Science 284:825–829
    [Google Scholar]
  13. Hussell T., Openshaw P. J. 1998; Intracellular IFN-γ expression in natural killer cells precedes lung CD8+ T cell recruitment during respiratory syncytial virus infection. Journal of General Virology 79:2593–2601
    [Google Scholar]
  14. Johnson A. J., Njenga M. K., Hansen M. J., Kuhns S. T., Chen L., Rodriguez M., Pease L. R. 1999; Prevalent class I-restricted T-cell response to the Theiler’s virus epitope Db: VP2121–130 in the absence of endogenous CD4 help, tumor necrosis factor alpha, gamma interferon, perforin, or costimulation through CD28. Journal of Virology 73:3702–3708
    [Google Scholar]
  15. Kagi D., Ledermann B., Burki K., Seiler P., Odermatt B., Olsen K. J., Podack E. R., Zinkernagel R. M., Hengartner H. 1994; Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369:31–37
    [Google Scholar]
  16. Kagi D., Ledermann B., Burki K., Zinkernagel R. M., Hengartner H. 1995a; Lymphocyte-mediated cytotoxicity in vitro and in vivo: mechanisms and significance. Immunological Reviews 146:95–115
    [Google Scholar]
  17. Kagi D., Seiler P., Pavlovic J., Ledermann B., Burki K., Zinkernagel R. M., Hengartner H. 1995b; The roles of perforin- and Fas-dependent cytotoxicity in protection against cytopathic and noncytopathic viruses. European Journal of Immunology 25:3256–3262
    [Google Scholar]
  18. Kagi D., Ledermann B., Burki K., Zinkernagel R. M., Hengartner H. 1996; Molecular mechanisms of lymphocyte-mediated cytotoxicity and their role in immunological protection and pathogenesis in vivo. Annual Review of Immunology 14:207–232
    [Google Scholar]
  19. Kodama T., Takeda K., Shimozato O., Hayakawa Y., Atsuta M., Kobayashi K., Ito M., Yagita H., Okumura K. 1999; Perforin-dependent NK cell cytotoxicity is sufficient for anti-metastatic effect of IL-12. European Journal of Immunology 29:1390–1396
    [Google Scholar]
  20. Kuwano K., Hagimoto N., Kawasaki M., Yatomi T., Nakamura N., Nagata S., Suda T., Kunitake R., Maeyama T., Miyazaki H., Hara N. 1999; Essential roles of the Fas–Fas ligand pathway in the development of pulmonary fibrosis. Journal of Clinical Investigation 104:13–19
    [Google Scholar]
  21. Kuwano K., Hagimoto N., Tanaka T., Kawasaki M., Kunitake R., Miyazaki H., Kaneko Y., Matsuba T., Maeyama T., Hara N. 2000; Expression of apoptosis-regulatory genes in epithelial cells in pulmonary fibrosis in mice. Journal of Pathology 190:221–229
    [Google Scholar]
  22. Liu A. N., Mohammed A. Z., Rice W. R., Fiedeldey D. T., Liebermann J. S., Whitsett J. A., Braciale T. J., Enelow R. I. 1999; Perforin-independent CD8+ T-cell-mediated cytotoxicity of alveolar epithelial cells is preferentially mediated by tumor necrosis factor- alpha: relative insensitivity to Fas ligand. American Journal of Respiratory Cell and Molecular Biology 20:849–858
    [Google Scholar]
  23. Lowin B., Beermann F., Schmidt A., Tschopp J. 1994a; A null mutation in the perforin gene impairs cytolytic T lymphocyte- and natural killer cell-mediated cytotoxicity. Proceedings of the National Academy of Sciences, USA 91:11571–11575
    [Google Scholar]
  24. Lowin B., Hahne M., Mattmann C., Tschopp J. 1994b; Cytolytic T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370:650–652
    [Google Scholar]
  25. Lowin B., Peitsch M. C., Tschopp J. 1995; Perforin and granzymes: crucial effector molecules in cytolytic T lymphocyte and natural killer cell-mediated cytotoxicity. Current Topics in Microbiology and Immunology 198:1–24
    [Google Scholar]
  26. Mullbacher A., Hla R. T., Museteanu C., Simon M. M. 1999a; Perforin is essential for control of ectromelia virus but not related poxviruses in mice. Journal of Virology 73:1665–1667
    [Google Scholar]
  27. Mullbacher A., Waring P., Tha Hla R., Tran T., Chin S., Stehle T., Museteanu C., Simon M. M. 1999b; Granzymes are the essential downstream effector molecules for the control of primary virus infections by cytolytic leukocytes. Proceedings of the National Academy of Sciences, USA 96:13950–13955
    [Google Scholar]
  28. Nash A. A., Sunil-Chandra N. P. 1994; Interactions of the murine gammaherpesvirus with the immune system. Current Opinion in Immunology 6:560–563
    [Google Scholar]
  29. O’Donnell D. R., Milligan L., Stark J. M. 1999; Induction of CD95 (Fas) and apoptosis in respiratory epithelial cell cultures following respiratory syncytial virus infection. Virology 257:198–207
    [Google Scholar]
  30. Ramshaw I. A., Ramsay A. J., Karupiah G., Rolph M. S., Mahalingam S., Ruby J. C. 1997; Cytokines and immunity to viral infections. Immunological Reviews 159:119–135
    [Google Scholar]
  31. Rosen D., Li J. H., Keidar S., Markon I., Orda R., Berke G. 2000; Tumor immunity in perforin-deficient mice: a role for CD95 (Fas/APO-1. Journal of Immunology 164:3229–3235
    [Google Scholar]
  32. Rossi C. P., McAllister A., Tanguy M., Kagi D., Brahic M. 1998; Theiler’s virus infection of perforin-deficient mice. Journal of Virology 72:4515–4519
    [Google Scholar]
  33. Sarawar S. R., Carding S. R., Allan W., McMickle A., Fujihashi K., Kiyono H., McGhee J. R., Doherty P. C. 1993; Cytokine profiles of bronchoalveolar lavage cells from mice with influenza pneumonia: consequences of CD4+ and CD8+ T cell depletion. Regional Immunology 5:142–150
    [Google Scholar]
  34. Schultz U., Chisari F. V. 1999; Recombinant duck interferon gamma inhibits duck hepatitis B virus replication in primary hepatocytes. Journal of Virology 73:3162–3168
    [Google Scholar]
  35. Smyth M. J., Sutton V. R., Kershaw M. H., Trapani J. A. 1996; Xenospecific cytotoxic T lymphocytes use perforin- and Fas-mediated lytic pathways. Transplantation 62:1529–1532
    [Google Scholar]
  36. Smyth M. J., Krasovskis E., Johnstone R. W. 1998; Fas ligand-mediated lysis of self bystander targets by human papillomavirus-specific CD8+ cytotoxic T lymphocytes. Journal of Virology 72:5948–5954
    [Google Scholar]
  37. Stevenson P. G., Belz G. T., Altman J. D., Doherty P. C. 1998; Virus-specific CD8+ T cell numbers are maintained during gamma- herpesvirus reactivation in CD4-deficient mice. Proceedings of the National Academy of Sciences, USA 95:15565–15570
    [Google Scholar]
  38. Stevenson P. G., Belz G. T., Altman J. D., Doherty P. C. 1999a; Changing patterns of dominance in the CD8+ T cell response during acute and persistent murine gamma-herpesvirus infection. European Journal of Immunology 29:1059–1067
    [Google Scholar]
  39. Stevenson P. G., Belz G. T., Castrucci M. R., Altman J. D., Doherty P. C. 1999b; A gamma-herpesvirus sneaks through a CD8+ T cell response primed to a lytic-phase epitope. Proceedings of the National Academy of Sciences, USA 96:9281–9286
    [Google Scholar]
  40. Stevenson P. G., Cardin R. D., Christensen J. P., Doherty P. C. 1999c; Immunological control of a murine gammaherpesvirus independent of CD8+ T cells. Journal of General Virology 80:477–483
    [Google Scholar]
  41. Stewart J. P., Usherwood E. J., Ross A., Dyson H., Nash T. 1998; Lung epithelial cells are a major site of murine gammaherpesvirus persistence. Journal of Experimental Medicine 187:1941–1951
    [Google Scholar]
  42. Sunil-Chandra N. P., Efstathiou S., Nash A. A. 1992; Murine gammaherpesvirus 68 establishes a latent infection in mouse B lymphocytes in vivo. Journal of General Virology 73:3275–3279
    [Google Scholar]
  43. Takizawa T., Fukuda R., Miyawaki T., Ohashi K., Nakanishi Y. 1995; Activation of the apoptotic Fas antigen-encoding gene upon influenza virus infection involving spontaneously produced beta-interferon. Virology 209:288–296
    [Google Scholar]
  44. Tay C. H., Welsh R. M. 1997; Distinct organ-dependent mechanisms for the control of murine cytomegalovirus infection by natural killer cells. Journal of Virology 71:267–275
    [Google Scholar]
  45. Tay C. H., Yu L. Y., Kumar V., Mason L., Ortaldo J. R., Welsh R. M. 1999; The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections. Journal of Immunology 162:718–726
    [Google Scholar]
  46. Topham D. J., Doherty P. C. 1998; Longitudinal analysis of the acute Sendai virus-specific CD4+ T cell response and memory. Journal of Immunology 161:4530–4535
    [Google Scholar]
  47. Topham D. J., Tripp R. A., Doherty P. C. 1997; CD8+ T cells clear influenza virus by perforin or Fas-dependent processes. Journal of Immunology 159:5197–5200
    [Google Scholar]
  48. Trapani J. A., Jans P., Smyth M. J., Froelich C. J., Williams E. A., Sutton V. R., Jans D. A. 1998; Perforin-dependent nuclear entry of granzyme B precedes apoptosis, and is not a consequence of nuclear membrane dysfunction. Cell Death and Differentiation 5:488–496
    [Google Scholar]
  49. Usherwood E. J., Brooks J. W., Sarawar S. R., Cardin R. D., Young W. D., Allen D. J., Doherty P. C., Nash A. A. 1997; Immunological control of murine gammaherpesvirus infection is independent of perforin. Journal of General Virology 78:2025–2030
    [Google Scholar]
  50. van den Broek M. F., Kagi D., Zinkernagel R. M., Hengartner H. 1995; Perforin dependence of natural killer cell-mediated tumor control in vivo. European Journal of Immunology 25:3514–3516
    [Google Scholar]
  51. van den Broek M. E., Kagi D., Ossendorp F., Toes R., Vamvakas S., Lutz W. K., Melief C. J., Zinkernagel R. M., Hengartner H. 1996; Decreased tumor surveillance in perforin-deficient mice. Journal of Experimental Medicine 184:1781–1790
    [Google Scholar]
  52. Vergelli M., Hemmer B., Muraro P. A., Tranquill L., Biddison W. E., Sarin A., McFarland H. F., Martin R. 1997; Human autoreactive CD4+ T cell clones use perforin- or Fas/Fas ligand-mediated pathways for target cell lysis. Journal of Immunology 158:2756–2761
    [Google Scholar]
  53. Virgin H. W., Speck S. H. 1999; Unraveling immunity to gamma-herpesviruses: a new model for understanding the role of immunity in chronic virus infection. Current Opinion in Immunology 11:371–379
    [Google Scholar]
  54. Weck K. E., Kim S. S., Virgin H. I., Speck S. H. 1999; Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells. Journal of Virology 73:3273–3283
    [Google Scholar]
  55. White D. W., MacNeil A., Busch D. H., Pilip I. M., Pamer E. G., Harty J. T. 1999; Perforin-deficient CD8+ T cells: in vivo priming and antigen-specific immunity against Listeria monocytogenes. Journal of Immunology 162:980–988
    [Google Scholar]
  56. Williams N. S., Engelhard V. H. 1996; Identification of a population of CD4+ CTL that utilizes a perforin- rather than a Fas ligand-dependent cytotoxic mechanism. Journal of Immunology 156:153–159
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-82-8-1971
Loading
/content/journal/jgv/10.1099/0022-1317-82-8-1971
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error